Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Business Wire
Four oral sessions to be presented, including validation data for Shield MCD test, selected for highly anticipated NCI Vanguard Study18 total abstracts to showcase significant developments in multiomic profiling with liquid and tissue biopsies across screening, recurrence monitoring and treatment selection PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present 18 abstracts, including four oral sessions, showcasing advances in multi-cancer detection and multiomic precision oncology testing enabled by its Guardant Infinity™ smart liquid biopsy platform at the 2025 American Association for Cancer Research (AACR) Annual Meeting, April 25-30 in Chicago.Key data that will be highlighted include:An oral presentation of performance data for the Shield™ MCD test, selected for the National Cancer Institute’s Vanguard Study evaluating emerging multi-cancer detection (MCD) technologyAdditional oral presentat
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Multiple Analysts Lift Guardant Health, Inc. (GH) Targets on Screening and Data Growth [Yahoo! Finance]Yahoo! Finance
- Guardant Health is the top performing healthcare services stock YTD [Seeking Alpha]Seeking Alpha
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at Canaccord Genuity Group Inc. from $100.00 to $125.00. They now have a "buy" rating on the stock.MarketBeat
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at Mizuho from $100.00 to $120.00. They now have an "outperform" rating on the stock.MarketBeat
- Guardant Health price target raised to $120 from $100 at BofA [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 12/23/25 - Form 4
- 12/18/25 - Form 4
- 12/18/25 - Form 4
- GH's page on the SEC website